Interferon alfacon-1
| Clinical data | |
|---|---|
| Routes of administration | Parenteral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| DrugBank | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C860H1353N227O255S9 |
| Molar mass | 19241.16 g·mol−1 |
  (what is this?) (verify) | |
Interferon alfacon-1 is a recombinant synthetic type I interferon used for the treatment of hairy cell leukemia, malignant melanoma and AIDS-related Kaposi's sarcoma.[1]
References
[edit]
 | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |